Binance Hits 78x Launchpad ROI, Yet HODLers Are Getting Wrecked âEUR" HereâEUR(TM)s Why
While market reports indicate Binance Launchpad hits 78x ROI for all-time highs, current figures suggest a steep decline for investors who have held tokens...
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
TORONTO, ON / ACCESS Newswire / June 22, 2026 /Adcore Inc. (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ) ("Adcore" or the "Company"), a global leader in AI marketing te...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
While market reports indicate Binance Launchpad hits 78x ROI for all-time highs, current figures suggest a steep decline for investors who have held tokens...
AI-focused crypto tokens have lost about 75% of their value year over year, erasing roughly $53 billion from the market. The post AI Tokens Shed 75% in a Y...
Lilly, Novo lock horns in India's obesity drug race
Stock Market Today: The Dow Jones index and the S&P 500 rise, aided by tech stock. Novo stock soared on FDA approval for a weight-loss pill.
Stock Market Today: The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Stock Market Today: The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Stock Market Today: The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
THORChain Launches Native Cross-Chain Swap Interface in Public Beta
Amplify has launched two new ETFs STBQ and TKNQ to track MarketVector stablecoin and tokenization indexes. STBQ covers firms tied to payments, infrastructu...
Novo Nordisk's weight-loss challenge in five charts
Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli Lilly.
Novo's Wegovy pill to test demand from consumers with cash